FR2776925B3 - USE OF AMINOTHIAZOLE DERIVATIVES FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF DISEASES LEADING TO DEMYELINATION - Google Patents

USE OF AMINOTHIAZOLE DERIVATIVES FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF DISEASES LEADING TO DEMYELINATION

Info

Publication number
FR2776925B3
FR2776925B3 FR9804284A FR9804284A FR2776925B3 FR 2776925 B3 FR2776925 B3 FR 2776925B3 FR 9804284 A FR9804284 A FR 9804284A FR 9804284 A FR9804284 A FR 9804284A FR 2776925 B3 FR2776925 B3 FR 2776925B3
Authority
FR
France
Prior art keywords
demyelination
medicines
preparation
treatment
aminothiazole derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9804284A
Other languages
French (fr)
Other versions
FR2776925A1 (en
Inventor
Daniel Aubert
Bernard Bourrie
Pierre Casellas
Marc Cluzel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Priority to FR9804284A priority Critical patent/FR2776925B3/en
Priority to PCT/FR1999/000744 priority patent/WO1999051226A1/en
Priority to AU29410/99A priority patent/AU2941099A/en
Publication of FR2776925A1 publication Critical patent/FR2776925A1/en
Application granted granted Critical
Publication of FR2776925B3 publication Critical patent/FR2776925B3/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9804284A 1998-04-07 1998-04-07 USE OF AMINOTHIAZOLE DERIVATIVES FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF DISEASES LEADING TO DEMYELINATION Expired - Lifetime FR2776925B3 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR9804284A FR2776925B3 (en) 1998-04-07 1998-04-07 USE OF AMINOTHIAZOLE DERIVATIVES FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF DISEASES LEADING TO DEMYELINATION
PCT/FR1999/000744 WO1999051226A1 (en) 1998-04-07 1999-03-31 Use of aminothiazole derivatives for preparing medicines for treating diseases causing demyelinization
AU29410/99A AU2941099A (en) 1998-04-07 1999-03-31 Use of aminothiazole derivatives for preparing medicines for treating diseases causing demyelinization

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9804284A FR2776925B3 (en) 1998-04-07 1998-04-07 USE OF AMINOTHIAZOLE DERIVATIVES FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF DISEASES LEADING TO DEMYELINATION

Publications (2)

Publication Number Publication Date
FR2776925A1 FR2776925A1 (en) 1999-10-08
FR2776925B3 true FR2776925B3 (en) 2000-05-26

Family

ID=9524926

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9804284A Expired - Lifetime FR2776925B3 (en) 1998-04-07 1998-04-07 USE OF AMINOTHIAZOLE DERIVATIVES FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF DISEASES LEADING TO DEMYELINATION

Country Status (3)

Country Link
AU (1) AU2941099A (en)
FR (1) FR2776925B3 (en)
WO (1) WO1999051226A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2656610B1 (en) * 1989-12-29 1992-05-07 Sanofi Sa DERIVATIVES OF 2-AMINO PHENYL-4 THIAZOLE, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION.
PT98674B (en) * 1990-08-15 1999-01-29 British Bio Technology METHOD FOR THE PREPARATION OF COMPOUNDS THAT ARE ANTAGONISTS OF THE ACTIVATION FACTOR OF PLATELETS FOR EXAMPLE DERIVATIVES OF IMIDAZOLE AND OF THEIR INTERMEDIARIES

Also Published As

Publication number Publication date
AU2941099A (en) 1999-10-25
WO1999051226A1 (en) 1999-10-14
FR2776925A1 (en) 1999-10-08

Similar Documents

Publication Publication Date Title
MA26790A1 (en) DIETETIC OR PHARMACEUTICAL COMPOSITION FOR USE IN THE PREVENTION OR TREATMENT OF HYPER-OXALURIA
IT1190466B (en) TREATMENT PROCEDURE FOR PHARMACEUTICAL FORMS OF DOSING COATED TO REDUCE THE COLLOSITY
FR2578421B1 (en) PHARMACEUTICAL COMPOSITIONS USEFUL FOR THE TREATMENT OF MEMORY DISORDERS
NO981911D0 (en) Use of rhodanine derivatives for the manufacture of a medicament for the treatment of Alzheimer's disease
FR2644692B1 (en) ORTHESIS FOR THREE-DIMENSIONAL REDUCTION OF SCOLIOSES
NO995221D0 (en) Sulfonamides for the treatment of endothelin-mediated diseases
FI990268A0 (en) Use of a Non-Peptide NK Antagonist for the Preparation of Medicines for the Treatment of Skin Diseases and Itching
OA09123A (en) Pharmaceutical composition for the prevention of sexually transmitted diseases.
SI0979079T1 (en) Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination
IL86423A0 (en) Pharmaceutical compositions for the treatment of alzheimer's disease
DZ3014A1 (en) Medicines for the treatment of hypertension.
NO20001869D0 (en) Procedures for the treatment of Alzheimer's disease
IT1206876B (en) EXTENDED PHARMACEUTICAL COMPOSITIONS RELATED FORMS OF DOSAGE AND PROCEDURE FOR THEIR PREPARATION
NO961797D0 (en) Use of benzopyran derivatives for the preparation of pharmaceutical compositions intended for the treatment of pathologies associated with the Na + -independent C1-HCO3 yields
BE891987A (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ORAL CAVITY DISEASES
FR2660192B1 (en) LIPOSOMIAL FORMULATION FOR TOPICAL OR VAGINAL ADMINISTRATION OF DRUGS.
NO975127D0 (en) Use of non-steroidal anti-inflammatory agents to improve the physiological compatibility of particulate pharmaceutical preparations
FR2635461B1 (en) USE OF TRICYCLIC DERIVATIVES FOR OBTAINING MEDICINES FOR TREATING STRESS
FR2744361B1 (en) APPLICATION OF PYRROLIDINE DERIVATIVES TO THE PREPARATION OF DRUGS FOR THE TREATMENT OF DRUG ABUSE OR SUBSTANCES GIVEN TO PHARMACOMANIES OR EXCESSIVE USE
FR2776925B3 (en) USE OF AMINOTHIAZOLE DERIVATIVES FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF DISEASES LEADING TO DEMYELINATION
FR2558372B1 (en) DRUG COMPOSITION FOR THE TREATMENT OF ACNE
FR2792199B3 (en) USE OF OSANETANT FOR THE PREPARATION OF MEDICINES USEFUL IN THE TREATMENT OF MOOD DISORDERS
FR2774289B1 (en) MEDICINE FOR THE TREATMENT OF APOPTOSIS DISORDERS
FR2759906B1 (en) USE OF MILNACIPRAN AND DERIVATIVES THEREOF FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF CERTAIN PSYCHIATRIC DISEASES
FR2718024B1 (en) Medicine and pharmaceutical composition for the treatment of inflammation.